SCHEMBL23219627

SCHEMBL23219627

CC(=O)OCCCC1NC(=O)OC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
CHRM5 P08912 2/20 0.31
CHRM1 P11229 2/20 0.31
CHRM3 P20309 2/20 0.31
PGR P06401 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRNB2 P17787 1/20 0.31
TBXA2R P21731 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA7 P36544 1/20 0.31
CHRNA4 P43681 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CHRNA10 Q9GZZ6 1/20 0.31
CHRNA9 Q9UGM1 1/20 0.31
TSHR P16473 1/20 0.31
GALR3 O60755 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23219623 0.80 DAO (0.30)
SCHEMBL23219624 0.69 POLB (0.38) ALDH1A1TSHRGAA
SCHEMBL24569734 0.68 TDP1 (0.48) TSHRGAA
SCHEMBL23319136 0.67 HSD17B10 (0.41) ALDH1A1GAA
SCHEMBL24420094 0.65 HTT (0.33) ALDH1A1SMN1; SMN2TSHRGAA
SCHEMBL315271 0.64 ALDH1A1 (0.74) ALDH1A1CHRM5CHRM1CHRM3PGR
SCHEMBL189930 0.64 ALDH1A1 (0.74) ALDH1A1CHRM5CHRM1CHRM3PGR
SCHEMBL23621970 0.64
SCHEMBL1576357 0.64 ALDH1A1 (0.48) ALDH1A1CHRM5CHRM1CHRM3PGR
SCHEMBL4931482 0.64 PLA2G10 (0.34) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3572408-B1 METHOD FOR PURIFYING AN AMINO ACID-N-CARBOXY ANHYDRIDE SHINETSU CHEMICAL CO (JP) 2021-10-27 EP disclosed
US-10975042-B2 Method for purifying an amino acid-n-carboxy anhydride SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975042-B2 Method for purifying an amino acid-n-carboxy anhydride NAAA, NPPA, NCAPH ALDH1A1 1912/4885CHRM5 737/4885CHRM1 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.